Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Baxter
Medtronic
McKinsey
Harvard Business School

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207921

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 207921 describes QVAR REDIHALER, which is a drug marketed by Norton Waterford and is included in one NDA. It is available from three suppliers. There are six patents protecting this drug. Additional details are available on the QVAR REDIHALER profile page.

The generic ingredient in QVAR REDIHALER is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.
Summary for 207921
Tradename:QVAR REDIHALER
Applicant:Norton Waterford
Ingredient:beclomethasone dipropionate
Patents:6
Formulation / Manufacturing:see details
Pharmacology for NDA: 207921
Suppliers and Packaging for NDA: 207921
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QVAR REDIHALER beclomethasone dipropionate AEROSOL, METERED;INHALATION 207921 NDA A-S Medication Solutions 50090-3459 50090-3459-0 1 INHALER in 1 CARTON (50090-3459-0) > 1 CANISTER in 1 INHALER > 120 AEROSOL, METERED in 1 CANISTER
QVAR REDIHALER beclomethasone dipropionate AEROSOL, METERED;INHALATION 207921 NDA RPK Pharmaceuticals, Inc. 53002-2436 53002-2436-3 1 INHALER in 1 CARTON (53002-2436-3) > 1 AEROSOL, METERED in 1 INHALER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;INHALATIONStrength0.04MG/INH
Approval Date:Aug 3, 2017TE:RLD:Yes
Patent:  Start TrialPatent Expiration:May 18, 2031Product Flag?YSubstance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:May 18, 2031Product Flag?YSubstance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:May 18, 2031Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 207921

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Norton Waterford QVAR REDIHALER beclomethasone dipropionate AEROSOL, METERED;INHALATION 207921-002 Aug 3, 2017   Start Trial   Start Trial
Norton Waterford QVAR REDIHALER beclomethasone dipropionate AEROSOL, METERED;INHALATION 207921-001 Aug 3, 2017   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Boehringer Ingelheim
Medtronic
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.